| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |